Advertisement Pharmaceutical Business review - Page 263 of 5284 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 31, 2026

Resilience and Lilly to increase US medicines production with $750m investment

Resilience and Eli Lilly and Company have expanded their partnership with a joint $750m investment to increase the production of Lilly’s KwikPen injectable device in Ohio, aiming to strengthen the supply of diabetes and obesity medicines in the US.

Continue
The expanded collaboration builds upon a partnership between Resilience and Lilly first formed in 2023. Credit: Jonathan Weiss / Shutterstock.com.
July 31, 2026

miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies

miRecule’s NAVIgGator platform will be combined with RBBL’s capabilities in peptide development and manufacturing. Credit: Gorodenkoff / Shutterstock.com.
July 30, 2026

Synlogic and Caldera sign merger agreement

CLD-423 is currently being studied in a Phase I clinical trial in healthy volunteers in Australia. Credit: MiniStocker / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use
  2. FDA grants fast track designation for HAYA Therapeutics’ HTX-001
  3. Eisai and CORE Biomedicine agree on global licence for oncology pipeline
  4. BioMarin and n-Lorem partner on early research for ReNU syndrome therapy
  5. argenx signs agreement to buy Forte Biosciences for $2.2bn

PRESS RELEASES

Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography